Form 4 for INSM INSMED Inc
Accepted 2025-02-05 00:00:00 ET · period of report 2025-02-03 · accession 0001628280-25-004076 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.94 | -18.8K | 379.5K | -5% | -$1.46M |
| DI | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $10.85 | +6,830 | 240.8K | +3% | +$74.1K |
| DMI | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | S - Sale+OE | $77.94 | -6,830 | 233.9K | -3% | -$532.3K |
| D | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $22.76 | +18.8K | 398.3K | +5% | +$426.8K |
| DI | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -6,830 | 211.8K | -3% | $0 |
| D | 2025-02-05 | 2025-02-03 | INSM | Lewis William | COB, CEO, Dir | M - OptEx | $0.00 | -18.8K | 56.2K | -25% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-03 | S | D | 1,872 | $76.35 | 396,171 | D By the Katie Procter Dynasty Trust | — | — | (F3) This is the weighted average sales price representing 1,872 shares sold at prices ranging from $76.00 to $76.57 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 2 | Common | Common Stock | 2025-02-03 | S | D | 9,869 | $77.97 | 386,302 | D By the Katie Procter Dynasty Trust | — | — | (F4) This is the weighted average sales price representing 9,869 shares sold at prices ranging from $77.29 to $78.28 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 3 | Common | Common Stock | 2025-02-03 | M | A | 6,830 | $10.85 | 240,754 | I | — | — | |
| 4 | Common | Common Stock | 2025-02-03 | S | D | 41 | $74.86 | 240,713 | I | — | — | |
| 5 | Common | Common Stock | 2025-02-03 | S | D | 745 | $76.43 | 239,968 | I | — | — | (F6) This is the weighted average sales price representing 745 shares sold at prices ranging from $76.10 to $76.90 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 6 | Common | Common Stock | 2025-02-03 | S | D | 3,463 | $77.95 | 236,505 | I | — | — | (F7) This is the weighted average sales price representing 3,463 shares sold at prices ranging from $77.24 to $78.23 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 7 | Common | Common Stock | 2025-02-03 | S | D | 241 | $75.25 | 398,043 | D By the Katie Procter Dynasty Trust | — | — | (F2) This is the weighted average sales price representing 241 shares sold at prices ranging from $74.86 to $75.83 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 8 | Common | Common Stock | 2025-02-03 | M | A | 18,750 | $22.76 | 398,284 | D By the Katie Procter Dynasty Trust | — | — | |
| 9 | Common | Common Stock | 2025-02-03 | S | D | 2,581 | $78.40 | 233,924 | I | — | — | (F8) This is the weighted average sales price representing 2,581 shares sold at prices ranging from $78.26 to $78.75 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 10 | Common | Common Stock | 2025-02-03 | S | D | 6,768 | $78.44 | 379,534 | D By the Katie Procter Dynasty Trust | — | — | (F5) This is the weighted average sales price representing 6,768 shares sold at prices ranging from $78.31 to $78.80 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request. |
| 11 | Derivative | Stock Option (right to buy) | 2025-02-03 | M | D | 6,830 | $0.00 | 211,800 | I | $10.85 · — to 2026-05-19 | 6,830 Common Stock | (F9) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |
| 12 | Derivative | Stock Option (right to buy) | 2025-02-03 | M | D | 18,750 | $0.00 | 56,250 | D By the Katie Procter Dynasty Trust | $22.76 · — to 2025-05-21 | 18,750 Common Stock | (F9) The options became exercisable based on the following vesting schedule: 25% vested on the first anniversary of the grant date and an additional 12.5% vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant. All options are currently exercisable. |